Back to Search

JOEL ROSENSTOCK, MD MPH

MD MPH

Infectious Disease Physician

NPI: 1497746408IndividualAccepts Medicare

Specialties, Licenses & Credentials

Infectious Disease PhysicianPrimary

Internal Medicine — Infectious Disease

Code: 207RI0200X

032036(GA)

CMS Specialties

PrimaryINFECTIOUS DISEASE

Additional

INTERNAL MEDICINE

Education

OTHER

Class of 1976

Research & Publications (20)

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
PMID 15288403·Pain·2004
3-trial
Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus.
PMID 19383032·Diabetes Obes Metab·2009
4-observational
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
PMID 19515413·Lancet·2009
4-observational
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
PMID 19526210·Diabetologia·2009
4-observational
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
PMID 19650754·Curr Med Res Opin·2009
2-rct
Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing.
PMID 19592625·Diabetes Care·2009
2-rct
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.
PMID 19609501·Diabetologia·2009
2-rct
Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
PMID 18535196·Diabetes Care·2008
2-rct
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
PMID 18678610·Diabetes Care·2008
4-observational
Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.
PMID 18093207·Diabetes Obes Metab·2008
1-meta
Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes.
PMID 18201206·Diabetes Obes Metab·2008
2-rct
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.
PMID 18596429·Neurosurgery·2008
8-other
SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes.
PMID 18678611·Diabetes Care·2008
2-rct
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
PMID 18458145·Diabetes Care·2008
2-rct
Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
PMID 18269437·Int J Clin Pract Suppl·2008
6-review
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes.
PMID 18355324·Diabetes Obes Metab·2008
4-observational
The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.
PMID 18438718·Int Urol Nephrol·2008
2-rct
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
PMID 18204830·Diabetologia·2008
4-observational
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
PMID 18796160·BMC Neurol·2008
4-observational
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
PMID 17947341·Diabetes Care·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3193 HOWELL MILL RD NW STE 125
ATLANTA, GA 30327

Location

Practice Location

3193 HOWELL MILL RD NW STE 125, ATLANTA, GA
(404) 352-1223

Quick Facts

NPI
1497746408
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
50
Publications
20

Are you this provider?

Claim Your Profile